Analysis of the circulating levels of IFN-γ and IL-17, two known inflammatory cytokines involved in pathogenesis of colitis, revealed that EVs treatment significantly reduced serum levels of IFN-γ, but not IL-17 levels in the serum in mice (Fig. 4d). Here, IFNG is linked to colitis.